GCTK — GLUCOTRACK INC (Healthcare >> Medical Instruments & Supplies)
GCTK FAQ
What is GCTK's ROE?
GLUCOTRACK INC reports a Return on Equity (ROE) of 1,984.61%.
What is GCTK's dividend yield?
GLUCOTRACK INC offers a dividend yield of 0.00%.
What is GCTK's Deepscope Quality Score?
Deepscope rates GCTK's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy GCTK?
Deepscope's AI Timing Score for GCTK is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does GCTK belong to?
GLUCOTRACK INC is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange.
|
USD 0.67
Price
0.00
(0.67%)
Day Change
|
|
|---|
GCTK, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.67 |
| PBV / Sector |
-4.86 / 4.59
|
| Earning Per Share | -2.72 |
| PE / Sector |
N/A / 36.68
|
| PEG or PE/Growth / Sector |
N/A / -1.22
|
| Average 1M Daily Value |
4.84 M
GREAT
|
| Average 1W Daily Value |
0.25 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-04 09:24:11 |
| Symbol | GCTK |
| Name | GLUCOTRACK INC |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 6.26 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 4.13 / 15,691.23 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 301 Route 17 North, Rutherford, NJ, United States, 07070
Phone: 201 842 7715
Website: https://glucotrack.com
Description: GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
Google